260 related articles for article (PubMed ID: 12687549)
1. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
Milner JM; Rowan AD; Elliott SF; Cawston TE
Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
[TBL] [Abstract][Full Text] [Related]
2. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
[TBL] [Abstract][Full Text] [Related]
5. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
6. Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases.
Lakey RL; Cawston TE
Rheumatology (Oxford); 2009 Oct; 48(10):1208-12. PubMed ID: 19690126
[TBL] [Abstract][Full Text] [Related]
7. Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.
Morgan TG; Rowan AD; Dickinson SC; Jones D; Hollander AP; Deehan D; Cawston TE
Ann Rheum Dis; 2006 Feb; 65(2):184-90. PubMed ID: 15975972
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta1 blocks the release of collagen fragments from boving nasal cartilage stimulated by oncostatin M in combination with IL-1alpha.
Hui W; Rowan AD; Cawston T
Cytokine; 2000 Jun; 12(6):765-9. PubMed ID: 10843761
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.
Shingleton WD; Ellis AJ; Rowan AD; Cawston TE
J Cell Biochem; 2000 Sep; 79(4):519-31. PubMed ID: 10996843
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
[TBL] [Abstract][Full Text] [Related]
12. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture.
Cawston TE; Ellis AJ; Humm G; Lean E; Ward D; Curry V
Biochem Biophys Res Commun; 1995 Oct; 215(1):377-85. PubMed ID: 7575616
[TBL] [Abstract][Full Text] [Related]
14. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
Hui W; Rowan AD; Richards CD; Cawston TE
Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
[TBL] [Abstract][Full Text] [Related]
16. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
Kozaci LD; Buttle DJ; Hollander AP
Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.
Hui W; Rowan AD; Cawston T
Ann Rheum Dis; 2001 Mar; 60(3):254-61. PubMed ID: 11171688
[TBL] [Abstract][Full Text] [Related]
18. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
[TBL] [Abstract][Full Text] [Related]
20. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
